Completed NA INTERVENTIONAL 1-arm NCT02811367

The HPV Self-test as a Test of Cure in Madagascar

The HPV Self-test as a Test of Cure in the Follow-up of HPV-positive Women in Madagascar

Sponsor: University Hospital, Geneva

Conditions Cervical Intraepithelial Neoplasia Grade 2/3 Human Papilloma Virus Infection

Interventions HPV test

Updated 6 times since 2017 Last updated: Oct 14, 2016 Started: Jun 30, 2016 Primary completion: Sep 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Cervical Intraepithelial Neoplasia Grade 2/3 and Human Papilloma Virus Infection, this trial is completed. The trial is conducted by University Hospital, Geneva and has accumulated 6 data snapshots since 2016. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Feb 2017 — Jun 2018 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jun 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Geneva

Data source: University Hospital, Geneva

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Ambanja, Madagascar